Gilead Sciences, Inc. is a leading biopharmaceutical company based in Foster City, California, renowned for its pioneering research and development of antiviral therapies aimed at treating infectious diseases, most notably HIV and hepatitis. The company’s industry-defining products, such as Harvoni and Sovaldi, have transformed treatment paradigms for chronic hepatitis C, underscoring Gilead's commitment to innovation and excellence in healthcare. With a growing and diversified therapeutic portfolio, Gilead is dedicated to addressing critical unmet medical needs, solidifying its role as a key player in enhancing global health outcomes and patient care.

NASDAQ

USA

HEALTHCARE

DRUG MANUFACTURERS - GENERAL

333 LAKESIDE DRIVE, FOSTER CITY, CA, UNITED STATES, 94404

December

$158 Billion

$14.1 Billion

19.69

6.46

$3.14

2.53%

0.334